Evidence map›Paper›PMID 41120942›Full record

ArticleBMC infectious diseases2025

Pre-exposure prophylaxis use and discontinuation among Brazilian gay, bisexual, and other men who have sex with men: examining the role of internalized homonegativity and discrimination.

Karine M Barreto, Thiago S Torres, Lucilene Freitas, Brenda Hoagland, Emília M Jalil, Valdilea G Veloso, Beatriz Grinsztejn, Paula M Luz

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Karine M BarretoSergio Arouca National School of Public Health, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil.
Thiago S TorresEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil.
Lucilene FreitasEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil.
Brenda HoaglandEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil.
Emília M JalilEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil.
Valdilea G VelosoEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil.
Beatriz GrinsztejnEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil.
Paula M LuzEvandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Av Brasil 4365, Rio de Janeiro, Brazil. paula.luz@ini.fiocruz.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPre-exposure prophylaxis (PrEP) is a highly effective HIV prevention strategy yet use and persistence among populations at high vulnerability to HIV in Brazil remains suboptimal. We sought to quantify internalized homonegativity and discrimination using multi-item validated instruments and to estimate their associations with PrEP use and discontinuation among gay, bisexual, and other men who have sex with men (MSM).

methodsA cross-sectional, web-based survey was conducted from November 2021 to January 2022, recruiting a convenience sample of MSM through dating apps and social media. The survey assessed sociodemographic characteristics, sexual behavior, substance use, HIV transmission knowledge (using the HIV Knowledge Assessment tool), internalized homonegativity (using the Reactions to Homosexuality Scale), and experiences of discrimination (using the Explicit Discrimination Scale). PrEP use was assessed with response options "I have never used PrEP" (henceforth "never used"), "I am currently using PrEP" (henceforth "current use"), and "I used PrEP in the past but stopped" (henceforth "discontinuation"). Unadjusted and adjusted associations between internalized homonegativity and discrimination and the outcomes a) "current use" of PrEP compared to "never use", and b) "discontinuation" compared to "current use", were estimated using logistic regression models.

resultsThe analytic sample consisted of 2,840 participants, with PrEP use patterns distributed as follows: 71.3% had never used PrEP, 22.8% were current users, and 5.9% had discontinued use. Unadjusted analyses indicated negative associations between internalized homonegativity and discrimination scores with current PrEP use (with higher scores leading to decreased odds of "current use"), and positive associations with PrEP discontinuation (higher scores leading to increased odds of "discontinuation"). After adjusting for potential confounders, higher internalized homonegativity was associated with decreased odds of "current use" (adjusted odds ratio [aOR] = 0.88, 95% confidence interval [CI] = 0.78-0.99) per 1 standard deviation [SD] increase in score) and more experiences of discrimination was associated with increased odds of "discontinuation" (aOR = 1.24, 95% CI: 1.03-1.50 per 1 SD increase in score). DISCUSSION: Our findings support the hypothesis that psychological distress from self-stigmatization and discrimination undermines PrEP use and persistence. Public health strategies need to integrate stigma-reduction and culturally competent, LGBTQIAPN+-affirming services to support PrEP as an effective prevention strategy.

Indexed as

HIV InfectionsHomosexuality, MalePre-Exposure ProphylaxisSexual and Gender MinoritiesAdolescentAdultBrazilCross-Sectional StudiesHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedSexual BehaviorSurveys and QuestionnairesYoung AdultBrazilLatin america & caribbeanMen who have sex with men (MSM)Pre-exposure prophylaxis (PrEP)PrEP discontinuationPrEP persistencePrEP use

Identifiers

PMID41120942
PMCPMC12538878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.